Clinical trials
Completed Hyperlipidemias trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2011 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 3 |
| AstraZeneca | 3 |
| Kastle Therapeutics, LLC | 2 |
| National Taiwan University Hospital | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| Chang Gung Memorial Hospital | 1 |
| Chi Mei Medical Hospital | 1 |
| Chung Shan Medical University | 1 |
| Golden Biotechnology Corporation | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 21 |
| Hypercholesterolemia | 6 |
| Homozygous Familial Hypercholesterolemia | 4 |
| Metabolic Diseases | 3 |
| Congenital Abnormalities | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Dyslipidemias | 2 |
| Genetic Diseases, Inborn | 2 |
| Hyperlipoproteinemia Type II | 2 |
| Hyperlipoproteinemias | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.